Back to Results

Phase I/Ib trial of radiotherapy in combination with Durvalumab (MEDI4736) prior to surgical resection for HPV negative squamous cell carcinoma of the head and neck (HNSCC)

Study category: Cancer

Is this Study for You?

Let's Get Started!




I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study



Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Sana Karam,  MD, PhD

Sana Karam, MD, PhD

Study ID

Protocol Number: 18-0606

More information available at NCT03635164


Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers